Tzu‐Chen Yen
Papers
1
Total Citations
16
H-Index
1
About
Dr. Tzu-Chen Yen is a leading figure in oncologic imaging, with a particular focus on prostate cancer management. His research centers on the comparative effectiveness of advanced imaging modalities for detecting biochemical recurrence after radical prostatectomy. In a landmark 2020 study, Dr. Yen systematically compared the diagnostic performance of 68Ga-PSMA-11 PET/CT against multiparametric magnetic resonance imaging (mpMRI) in Taiwanese patients following robot-assisted radical prostatectomy. This work, which has garnered 16 citations, provided critical evidence on the superior sensitivity of PSMA-PET for identifying recurrent disease, directly influencing clinical decision-making in post-surgical surveillance. By rigorously evaluating these cutting-edge technologies in an Asian cohort, Dr. Yen has helped bridge gaps in global prostate cancer imaging guidelines. His contributions are essential for urologists and nuclear medicine specialists seeking to optimize restaging protocols, ultimately improving outcomes for patients with biochemically recurrent prostate cancer through more precise and timely detection of residual or metastatic disease.
Research Focus
Key Achievements
Top Papers
- 1